Frequency of anticancer drug use at the end of life: a scoping review.

Endre SzigethyRosario DorantesMiguel SugrañesMeisser Madera Ivan Sola Gerard Urrútia Xavier Bonfill

Published in: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico (2023)

This comprehensive description of publications on anticancer drug use at end of life underscores the importance of methodological factors when designing studies and comparing outcomes.

Keyphrases

insulin resistance
metabolic syndrome
adipose tissue
skeletal muscle